Prevalence of Attention Deficit Hyperactivity Disorder and Its Comorbidities

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06146595
Collaborator
(none)
200
21

Study Details

Study Description

Brief Summary

Estimate the prevalence of attention deficit hyperactivity disorder and comorbid psychiatric disorder among primary school students in New Valley governorate.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    ADHD (attention deficit hyperactivity disorder) is a common neurodevelopmental disorder characterized by hyperactivity, impulsivity, and inattention. Its prevalence ranges between 5.9 and 7.1% worldwide. Etiology of ADHD included combinations of genetic, neurological, and environmental factors. ADHD is more often a complex disorder with a high rate of associated comorbid conditions. Comorbid conditions are prevalent among people with ADHD and increase its burden and complexity of management. Children with ADHD are at a higher risk than children without ADHD for developing other psychiatric disorders. Most children with ADHD also have at least one comorbid condition, the presence of which contributes to poorer long-term outcomes. The pattern of comorbidities is influenced by age and sex; externalizing disorders are more common in younger ages and male participants, in contrast, internalizing disorders are more prevalent among older ages and female participants. Comorbidity involving ADHD and learning disorders is frequent, ranging from 25 to 40%. Other disorders likely to co-occur with ADHD are: bipolar disorders (11-75%), tic disorders (20%), obsessive compulsive disorders (6-15%). Children with ADHD may show several motor problems: longer and more variable reaction times, increased variability in speed and less accurate response reengagement, and impaired orienting responses, and increased number of responses with very long reaction times. Neurological soft sign have been associated with inattention and behavior difficulties for decades. Some researchers argue that these signs should be included in the diagnosis of ADHD.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Prevalence Study of Attention Deficit Hyperactivity Disorder and Its Comorbidities Among a Sample of Primary School Students in New Valley Governorate
    Anticipated Study Start Date :
    Feb 1, 2024
    Anticipated Primary Completion Date :
    Sep 1, 2025
    Anticipated Study Completion Date :
    Nov 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Detect the prevalence of attention deficit hyperactivity disorder among primary school students in New Valley governorate [Baseline]

      the child and his parents will be subjected to special psychiatric interview sheet designed at child psychiatric unit at Assiut university hospital for collecting detailed psychiatric history of the child and assessment of the child through a detailed interview including mental state examination and neurological examination.also the child will be subjected to Conner's Parent Rating Scale-revised (L).

    Secondary Outcome Measures

    1. Detect comorbid psychiatric disorder among ADHD primary school student in New Valley governorate. [Baseline]

      the child will be subjected to Child behavior checklist (CBCL), parent form

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Age: 6-17 years. Sex: both sexes will be included in the study.

    Exclusion Criteria:

    Age: less than 6 years or more than 17 years. Patients with major neurological deficits, cerebral palsy. Patient who refusing to participate in the study or their caregiver refusing to give informed consent. Mentally retarded children.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mahmood Mohammed Yosry Abdelsatar Mohammed, assistant lecturer, Assiut University
    ClinicalTrials.gov Identifier:
    NCT06146595
    Other Study ID Numbers:
    • ADHD and its comorbidity
    First Posted:
    Nov 24, 2023
    Last Update Posted:
    Nov 24, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 24, 2023